首页 / 资料库 / 文献详情

[Significance of NUDT15 gene in individualized treatment with 6-mercaptopurine in children with acute lymphoblastic leukemia].

Jing HeLing Liu

2019PubMedMedicine被引 2开放获取

出版方页面 →

摘要

As an important drug during maintenance treatment of acute lymphoblastic leukemia (ALL), 6-mercaptopurine (6-MP) has several side effects, including hepatotoxicity and bone marrow suppression. Since its tolerability varies from person to person, 6-MP treatment should be individualized. The deficiency of thiopurine methyltransferase (TPMT) enzyme activity is associated with 6-MP intolerance. There is a lower frequency of mutation in TPMT alleles among Asian patients. Recent studies have shown that in ALL patients with NUDT15 gene mutation, the maximum tolerated dose of 6-MP is lower than the conventional dose. The article reviews the significance of NUDT15 gene in individualized treatment with 6-MP in children with ALL.

引用本文(GB/T 7714)

Jing He, Ling Liu. [Significance of NUDT15 gene in individualized treatment with 6-mercaptopurine in children with acute lymphoblastic leukemia].[J]. PubMed, 2019.

引文网络

参考文献与被引分析加载中…

DOI:https://doi.org/10.7499/j.issn.1008-8830.2019.01.018

本站仅收录题录与摘要供学习参考,全文版权归属出版方;如有侵权请联系我们删除。